Gerardo TurcattiSenior scientific level (R&D) with extensive experience in the management of multidisciplinary technological projects. Prof. Gerardo Turcatti, directs the academic technological platform, Biomolecular Screening Facility (BSF) at the EPFL he created in 2006. In the framework of the NCCR-Chemical Biology, he is project leader of the program ACCESS (An Academic Chemical Screening Platform for Switzerland). Previously he co-founded and acted as CTO of Manteia S.A., a Swiss-based company that developed high throughput DNA sequencing technologies currently owned by Illumina and used in the ‘Next Generation Sequencing’ instruments. Prior to this experience, Prof. Turcatti had a long multidisciplinary career in R&D divisions of Biotechnology and Pharmaceutical companies with extensive expertise in several Chemical Biology-related disciplines such as Drug Screening, Chemical Biology, Bio-analytical Chemistry, DNA and Protein Chemistry. Prof. Turcatti earned his Master in Chemical Engineering at the University of Geneva and his PhD in Chemistry and Biochemistry from the EPFL where he received the award for the best doctoral thesis of the year.
René SalathéRené Paul Salathé is Professor em. at EPFL since 2009. He is currently a technology consultant for several companies and he serves as an expert member of the Life Science team at the Swiss Innovation Agency (KTI/CTI) in Bern, on the scientific advisory board of the Fraunhofer-Institut für Lasertechnik ILT in Aachen, and he participates on expert panels for the Deutsche Forschungsgemeinschaft. He is a member of the Swiss Society for Optics and Microscopy, the European Optical Society, the Optical Society of America, a senior member of the IEEE, and a life time member of the Swiss Physical Society.
René Paul Salathé received the MS, PhD, and Habilitation (Privatdozent) degrees at the University of Bern in 1970, 1974, and 1979, respectively. Prior to his appointment at EPFL in 1989, he was directing the division "Material Testing and Technology" at the research and development center of the Swiss PTT. He has been active in the fields of semiconductor lasers, fibers, integrated optics, laser processing, and biomedical optics. The results of his research activities have been published more than 250 scientific contributions and 37 PhD theses at EPFL. Several start-up companies have been founded based on patents elaborated in his laboratory and/or by his PhD students. His actual research interests are in the areas of laser tweezers in micro-fluidics for biochemical applications and in optical fiber sensor applications.
Pierre GönczyPierre Gönczy obtained his PhD from The Rockefeller University (New York, USA) in 1995 and joined the laboratory of Tony Hyman at the EMBL (Heidelberg, Germany) as a postdoctoral fellow in 1996. He started his own laboratory at ISREC in 2000. In 2005, he became Associate Professor at the EPFL School of Life Sciences, and was promoted Full Professor in 2009.
